EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A New Staging System Using Right Atrial Strain in Patients with Immunoglobulin Light-Chain Cardiac Amyloidosis

Hiroki Usuku, Eiichiro Yamamoto, Daisuke Sueta, Rumi Shinriki, Fumi Oike, Noriaki Tabata, Masanobu Ishii, Shinsuke Hanatani, Tadashi Hoshiyama, Hisanori Kanazawa, Yuichiro Arima, Seiji Takashio und 5 weitere

ESC Heart Failure · 2024

DOI: 10.1002/ehf2.14710 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ESC Heart Failure, 2024. Verfasst von Hiroki Usuku und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Kumamoto University Hospital, Kumamoto, Japan. Hauptthemen laut MEDLINE: Heart Atria, Immunoglobulin Light-chain Amyloidosis, Cardiomyopathies. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology of Japan, Japan Society for the Promotion of Science, Pfizer Japan Incorporated.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

There are minimal data on the prognostic impact of right atrial strain during the reservoir phase (RASr) in patients with immunoglobulin light-chain (AL) cardiac amyloidosis. Methods and results Among 78 patients who were diagnosed with AL cardiac amyloidosis at Kumamoto University Hospital from 2007 to 2022, 72 patients with sufficient two-dimensional speckle tracking imaging data without chemotherapy before the diagnosis were retrospectively analysed. During a median follow-up of 403 days, 31 deaths occurred. Age and the rate of male sex were not significantly different between the all-cause death group and the survival group (age, 70.4 ± 8.8 years vs. 67.0 ± 10.0 years, P = 0.14, male sex, 65% vs. 66%, P = 0.91). The estimated glomerular filtration rate (eGFR) was significantly lower, and B-type natriuretic peptide (BNP) and high sensitivity cardiac troponin T (hs-cTnT) were significantly higher, in the all-cause death group versus the survival group (eGFR, 48.2 ± 21.0 mL/min/1.73 m2 vs. 59.4 ± 24.4 mL/min/1.73 m2, P < 0.05, BNP, 725 [360–1312] pg/mL vs. 123 [81–310] pg/mL, P < 0.01, hs-cTnT, 0.12 [0.07–0.18] ng/mL vs. 0.05 [0.03–0.08] ng/mL, P < 0.01). Left ventricular (LV) global longitudinal strain (GLS) (LV-GLS), left atrial strain during the reservoir phase (LASr), right ventricular GLS (RV-GLS), and RASr were significantly lower in the all-cause death group versus the survival group (LV-GLS, 8.5 ± 4.3% vs. 11.8 ± 3.8%, P < 0.01, LASr, 8.8 ± 7.1% vs. 14.3 ± 8.1%, P < 0.01, RV-GLS, 11.6 ± 5.1% vs. 16.4 ± 3.9%, P < 0.01, RASr, 10.2 ± 7.3% vs. 20.7 ± 9.5%, P < 0.01). RASr was significantly associated with all-cause death after adjusting for RV-GLS, LV-GLS and LASr (hazard ratio [HR]: 0.91, 95% confidence interval [95% CI]: 0.83–0.99, P < 0.05). RASr and log-transformed BNP were significantly associated with all-cause death after adjusting for log-transformed troponin T and eGFR (RASr, HR: 0.93, 95% CI: 0.87–1.00, P < 0.05; log-transformed BNP, HR: 2.10, 95% CI: 1.17–3.79, P < 0.05). The optimal cut-off values were RASr: 16.4% (sensitivity: 66%, specificity: 84%, area under curve [AUC]: 0.81) and BNP: 311.2 pg/mL (sensitivity: 83%, specificity: 78%, AUC: 0.82) to predict all-cause mortality using ROC analysis. Kaplan–Meier analysis revealed that patients with low RASr (<16.4%) or high BNP (>311.2 pg/mL) had a significantly high probability of all-cause death (both, P < 0.01). We devised a new staging score by adding 1 point if RASr decreased or BNP levels increased more than each cut-off value. The HR for all-cause death using score 0 as a reference was 5.95 (95% CI: 1.19–29.79; P < 0.05) for score 1 and 23.29 (95% CI: 5.37–100.98; P < 0.01) for score 2.

Conclusions

The new staging system using RASr and BNP predicted prognosis in patients with AL cardiac amyloidosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart AtriaImmunoglobulin Light-chain AmyloidosisCardiomyopathiesHumansMaleFemaleRetrospective StudiesAgedPrognosisEchocardiographyFollow-Up StudiesSurvival RateMiddle Aged

Stichwörter der Autor:innen

B‐type natriuretic peptideImmunoglobulin light‐chain cardiac amyloidosisRight atrial strain during the reservoir phase

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Kumamoto University Hospital, Kumamoto, Japan.
  • Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
  • Center of Metabolic Regulation of Healthy Aging, Kumamoto University Faculty of Life Sciences, Kumamoto, Japan.
  • Department of Hematology, Rheumatology, and Infectious Diseases, Graduate School of Medical Science, Kumamoto University, Kumamoto, Japan.
  • Department of Diagnostic Radiology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
  • Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.

Förderung

  • Ministry of Education, Culture, Sports, Science and Technology of Japan
  • Japan Society for the Promotion of Science
  • Pfizer Japan Incorporated

Zitieren

APA

Usuku, H., Yamamoto, E., Sueta, D., Shinriki, R., Oike, F., Tabata, N., Ishii, M., Hanatani, S., Hoshiyama, T., Kanazawa, H., Arima, Y., Takashio, S., Kawano, Y., Oda, S., Kawano, H., Ueda, M., & Tsujita, K. (2024). A New Staging System Using Right Atrial Strain in Patients with Immunoglobulin Light-Chain Cardiac Amyloidosis. ESC Heart Failure. https://doi.org/10.1002/ehf2.14710

Vancouver

Usuku H, Yamamoto E, Sueta D, Shinriki R, Oike F, Tabata N, et al. A New Staging System Using Right Atrial Strain in Patients with Immunoglobulin Light-Chain Cardiac Amyloidosis. ESC Heart Failure. 2024. doi:10.1002/ehf2.14710

BibTeX
@article{Usuku2024,
  author = {Usuku, Hiroki and Yamamoto, Eiichiro and Sueta, Daisuke and Shinriki, Rumi and Oike, Fumi and Tabata, Noriaki and Ishii, Masanobu and Hanatani, Shinsuke and Hoshiyama, Tadashi and Kanazawa, Hisanori and Arima, Yuichiro and Takashio, Seiji and Kawano, Yawara and Oda, Seitaro and Kawano, Hiroaki and Ueda, Mitsuharu and Tsujita, Kenichi},
  title = {A New Staging System Using Right Atrial Strain in Patients with Immunoglobulin Light-Chain Cardiac Amyloidosis},
  journal = {ESC Heart Failure},
  year = {2024},
  doi = {10.1002/ehf2.14710}
}
Kostenlos starten →